Through the work of the CVS Health Emergency Response & Resiliency Team and Infectious Disease Response Team, we continue to actively monitor the current international and domestic environment for coronavirus-related risks and prepare accordingly. Specifically, these teams are:
Insurance coverageEffective March 6, 2020, a number of COVID-19 resources are available to Aetna members, including:
Medication accessOn March 9, 2020, CVS Health announced additional COVID-19 resources to increase patient access to medications.
Product supplyWe are working with our suppliers to meet customer demand for products being sought in relation to the COVID-19 outbreak. This demand may cause temporary shortages for certain products at some store locations and we re-supply those stores as quickly as possible.
Medication supplyWe are closely monitoring the global manufacturing environment. We do not see any disruptions to the supply chain that will affect our ability to fill prescriptions for plan members, now and into the near future. We always encourage members to refill maintenance medications in a timely manner.
In addition to CVS Health’s monitoring, the Food and Drug Administration is closely monitoring medications that are made in China or rely solely on active pharmaceutical ingredients from China. The agency also said it has reminded more than 180 manufacturers to notify the FDA of any potential supply chain disruptions.
MinuteClinicCVS Health and MinuteClinic are collaborating closely with local health departments related to COVID-19. At this time, there is not a point-of-care test available for COVID-19 in ambulatory care settings such as MinuteClinic. When we see a patient who is presenting with symptoms of a lower-respiratory tract illness (e.g., coughing, shortness of breath), we ask about their recent travel history (e.g., timeframe and location) and evaluate relevant risk factors to determine their risk of exposure to COVID-19. These visits may also include recommending further consultation with a physician to determine if a higher level of care is required.
At this time, there is not a point-of-care test available for COVID-19 in ambulatory care settings such as MinuteClinic.
Video visitsMinuteClinic offers patients the opportunity to request a Video Visit in 40 states and Washington, D.C. Virtual care options such as video visits can be an effective way to evaluate and treat viruses from the comfort of one’s home, while minimizing exposure to other potentially contagious viruses.
Workforce planningWe are actively monitoring the current environment for COVID-19 related risks and we continue to implement plans and processes to help keep our employees safe and healthy. For example, effective March 3 and until further notice, we cancelled non-essential domestic and international business travel, as well as group meetings of 20 people or more. In addition, any employees returning from a CDC-designated Level 2 or Level 3 advisory area must observe a mandatory 14-day work from home period.
As the COVID-19 outbreak continues to evolve, we are taking additional actions to help reduce the spread of the virus. To support public health guidance from medical experts about “social distancing,” effective March 12 and until further notice, we are giving our employees the option to work from home if their role enables them to do so. Reducing the number of people in the office will also help make the work environment safer for employees whose roles require them to be in an office or facility. Managers of office-based colleagues unable to work from home will remain in the office to support their teams. We are committed to extending resources, when possible, to enable more office-based employees to work from home. We will also support employees in locations such as stores, mail service pharmacies, call centers and distribution centers with guidance and resources to help protect their health while at work.